Candidosis, a new challenge

Clinics in Dermatology

Volumn 28, Issue 2, 2010, Pages 178-184

  López Martínez, Rubén ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE DERIVATIVE; AMOROLFINE; AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; BIFONAZOLE; BUTOCONAZOLE; CASPOFUNGIN; CICLOPIROXOLAMINE; CLOTRIMAZOLE; ECHINOCANDIN; FENTICONAZOLE; FLUCONAZOLE; IMIDAZOLE DERIVATIVE; ISOCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICAFUNGIN; MICONAZOLE; MORPHOLINE DERIVATIVE; NYSTATIN; OMOCONAZOLE; OXICONAZOLE; POSACONAZOLE; PYRROLE DERIVATIVE; TERBINAFINE; TERCONAZOLE; TRIAZOLE DERIVATIVE; UNINDEXED DRUG; VORICONAZOLE;

BALANOPREPUTIAL CANDIDIASIS; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA FAMATA; CANDIDIASIS; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DRUG DOSE INCREASE; DRUG EFFICACY; FUNGUS ISOLATION; GRANULOMA; HISTOPATHOLOGY; HUMAN; LABORATORY DIAGNOSIS; MICROSCOPY; MUCOCUTANEOUS CANDIDIASIS; NONHUMAN; NOTE; ONYCHIA; ONYCHOMYCOTIC CANDIDIASIS; PARONYCHIA; PRIORITY JOURNAL; SINGLE DRUG DOSE; SKIN CANDIDIASIS; SMEAR; THRUSH; VAGINA CANDIDIASIS; YARROWIA LIPOLYTICA;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; ECHINOCANDINS; HUMANS; IMIDAZOLES; NAPHTHALENES; NYSTATIN; TRIAZOLES;

EID: 77950215343     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2009.12.014     Document Type: Note

References (16)

1. Pappas P.J., Kauffman C.A., et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:503-535.
2. Manzano-Gayosso P., Hernández-Hernández F., Bazán-Mora E., et al. Identificación y tipificación de levaduras aisladas de pacientes de un hospital de la Ciudad de México. Rev Argent Microbiol 2000, 32:1-6.
3. Anaisse E.J., McGiniss M.R., Pfaller M.A. Clinical mycology 2003, 608. Churchill Livingstone, New York.
4. Sullivan D.J., Westerneng T.J., Haynes K.A., et al. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995, 141:1507-1521.
5. Alcoba-Flores J., Méndez-Alvarez S., Cano J., et al. Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J Clin Microbiol 2005, 43:4107-4111.
6. Krcmery V., Barnes A.J. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002, 50:246-260.
7. Agarwal S., Thakur K., Kanga A., et al. Catheter-related candidemia caused by Candida lipolytica in a child with tubercular meningitis. Indian J Pathol Microbiol 2008, 51:298-300.
8. Samaranayake L.P. Nuevas perspectivas en la epidemiología y etiopatogénesis de la candidiasis oral. Gac Med Bilbao 2001, 98:E15-E16.
9. López-Martínez R. Fármacos útiles en el tratamiento de las micosis. Guía de farmacología y terapéutica 2009, 276-281. México, DF, McGraw Hill. 2nd ed. R. Rodríguez-Carranza, H. Vidrio-López, A.E. Campos Sepúlveda (Eds.).
10. Chen S., Sorrell T. Antifungal agents. Med J Austral 2007, 187:404-409.
11. Vázquez J.A., Skiest D.J., Nieto L., et al. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. Clin Infect Dis 2006, 42:1179-1186.
12. Skiest D.J., Vázquez J.A., Anstead G.M., et al. Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection. Clin Infect Dis 2007, 44:607-614.
13. Vázquez del Mercado E., Arenas R. Antimicóticos en niños. Dermatol Peditr Lat 2007, 5:155-164.
14. Bennet J.E. Echinocandins for candidemia in adults without neutropenia. N Engl J Med 2006, 355:1154-1159.
15. Jarvis B., Figgitt D.P., Scott L.J. Micafungin. Drug 2004, 64:969-982.
16. Scott L.J., Simpson D. Voriconazole. A review of it use in the management of invasive fungal infection. Drugs 2007, 67:269-298.